Gene expression of endothelial type isoform of nitric oxide synthase in various tissues of stroke-prone spontaneously hypertensive rats

Hypertension Research

Volumn 20, Issue 1, 1997, Pages 43-49

  Seki, Toshirou ^a   Naruse, Mitsuhide ^a   Naruse, Kiyoko ^a   Katafuchi, Takeshi ^b   Lodhi, Khalid Mahmud ^b   Yoshimoto, Takanobu ^a   Hagiwara, Hiromi ^b   Demura, Hiroshi ^a   Hirose, Shigehisa ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Gene expression; Nitric oxide; Nitric oxide synthase; Stroke prone spontaneously hypertensive rats

Indexed keywords

MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; GENE EXPRESSION; HEMODYNAMICS; HYBRIDIZATION; MALE; MESSENGER RNA SYNTHESIS; NONHUMAN; PATHOPHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRESS; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030895502     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.43     Document Type: Article

References (38)

1. Förstermann U, Closs EI, Pollock JS, et al Nitric oxide synthase isozymes characterizatipn, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121-1131.
2. Rees DD, Palmer RM, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375-3378.
3. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S: Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 1990; 15: 486-492.
4. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
5. Alheid U, Fröhlich JC, Förstermann U: Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res 1987; 47: 561-571.
6. Kubes P, Suzuki M, Granger DM: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
7. Moncada S, Higgs A: The L-arginine nitric oxide pathway. New Engl J Med 1993; 329: 2002-2012.
8. Stamler JS: Redox signaling: nitrosylation and relatcd target interactions of nitric oxide. Cell 1994; 78: 931-936.
9. Nabika T, Nara Y, Ikeda K, Endo J, Yamori Y: Genetic heterogeneity of the spontaneously hypertensive rat. Hypertension 1991; 18: 12-16.
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorofonn extraction. Anal Biochem 1987; 162: 156-159.
11. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
12. Yoshimoto T, Naruse M, Naruse K, et al: Modulation of vascular natriuretic peptide receptor gene expression in hypertensive and obese hyperglycemic rats. Endocrinology 1995; 136: 2427-2434.
13. Simmons DM, Arriza JL, Swanson LW: A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J Histotechnol 1989; 12: 169-181.
14. Samoszuk M, Nansen L: Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990; 75: 13-16.
15. Pollock JS, Nakane M, Buttery LDK, et al: Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 1993; 265: C1379-C1387.
16. Sessa WC, Harrison JK, Luthin DR, Pollock JS, Lynch KR: Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase. Hypertension 1993; 21: 934-938.
17. G-monomethyl-L-arginine or indomethasin. J Pharmacol Exp Ther 1995; 272: 452-459.
18. Seki T, Hagiwara H, Naruse K, et al: In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes. Biochem Biophys Res Commun 1996; 218: 601-605.
19. Arnal JF, Battle T, Menard J, Michel JB: Vasodilator effect of nitric oxide is a necessary counter-regulation in the spontaneously hypertensive rats. Arch Mal Coeur 1993; 86: 1193-1196.
20. Angus JA, Dyke AC, Jennings GL, et al: Release of endothelium-derived relaxing factor from resistance arteries in hypertension. Kidney Int 1992; 37 (Suppl): S73-S78.
21. Sawada Y, Sakamaki T, Nakamura T, Sato K, Ono Z, Murata K: Release of nitric oxide in response to acetylcholine is unaltered in spontaneously hypertensive rats. J Hypertens 1994; 12: 745-750.
22. Hayakawa H, Hirata Y, Suzuki E, et al: Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol 1993; 264: H1535-H1541.
23. Hayakawa H, Hirata Y, Suzuki E, et al: Endothelium-derived relaxing factors in the kidney of spontaneously hypertensive rats. Life Sci 1995; 56: PL401-PL408.
24. Nathan C, Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728.
25. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-918.
26. Dicderich D, Yang ZH, Buhler FR, Luscher TF: Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway. Am J Physiol 1990; 258: H445-H451.
27. Soloviev AI, Stefanov AV, Bazilyuk OV, Sagach VF: Phospholipid vesicles (liposomes) restore endothelium-dependent cholinergic relaxation in thoracic aorta from spontaneously hypertensive rats. J Hypertens 1993; 11: 623-627.
28. Koller A, Huang A: Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res 1994; 74: 416-421.
29. Koller A, Huang A: Shear stress-induced dilation is attenuated in skeletal muscle arterioles of hypertensive rats. Hypertension 1995; 25: 758-763.
30. Taguchi H, Faraci FM, Kitazono T, Heistad DD: Relaxation of the aorta during hypoxia is impaired in chronically hypertensive rats. Hypertension 1995; 25: 735-738.
31. Malinski T, Kapturczak M, Dayharsh J, Bohr D: Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 1993; 194: 654-658.
32. Hirata Y, Hayakawa H, Kakoki M, et al: Nitric oxide release from kidneys of hypertensive rats treated with imidapril. Hypertension 1996; 27: 672-678.
33. Nishida K, Harrison DG, Navas JP, et al: Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90: 2092-2096.
34. Marsden PA, Heng HHQ, Scherer SW, et al: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488.
35. Myatt L, Brockman DE, Eis A, Pollock JS: Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 1993; 14: 487-495.
36. Tracey WR, Pollock JS, Murad F, Nakane M, Förstermann U: Identification of an endothelial-like type III NO synthase in LLC-PK1 kidney epithelial cells. Am J Physiol 1994; 266: C22-C28.
37. Balligand JL, Kobzik L, Han X, et al: Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995; 270: 14582-14586.
38. Numaguchi K, Egashira K, Takemoto M, et al: Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 1995; 26: 957-962.